IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q3 2024 Holdings

Filed 2024-11-14 | 12 holdings | $24.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Xeris Biopharma Holdings Inc(XERS)COM98422E103$14.6M5,113,34860.3%
Rezolute Inc(RZLT)COM NEW76200L309$6.4M1,318,96726.5%
Spdr S&P 500 ETF TR(SPY)TR UNIT78462F103$1.6M2,8676.8%
Berkshire Hathaway Inc del(BRK/B)CL B NEW084670702$529.6K1,1512.2%
Bicara Therapeutics Inc(BCAX)COM055477103$278.7K10,9411.2%
Mind Medicine Mindmed Inc(BRD1EUR)COM NEW60255C885$193.9K34,0730.8%
Lexeo Therapeutics Inc(LXEO)COM52886X107$161.4K17,8510.7%
Abivax SA(ABVX)SPONSORED ADS00370M103$130.9K11,3650.5%
Kyverna Therapeutics Inc(KYTX)COM501976104$112.4K22,9810.5%
Compass Therapeutics Inc(CMPX)COM20454B104$80.0K43,4650.3%
Context Therapeutics Inc(CNTX)COM21077P108$36.1K18,4030.1%
Adicet BIO Inc(TORCEUR)COM007002108$25.2K17,4880.1%